Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Schmid

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Expert Review of Hematology|November 18, 2015
Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failureHolger Schmid
Expert Opinion on Pharmacotherapy|March 20, 2013
Peginesatide for the treatment of renal disease-induced anemiaHolger Schmid
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2014
Cost-effectiveness of continuous erythropoietin receptor activator in anemiaHolger Schmid
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 7, 2010
Erythropoiesis stimulating agents and anaemia of end-stage renal diseaseHolger Schmid, Helmut Schiffl
Sozial- Und Praventivmedizin|January 7, 2003
Repeated self-reported injuries and substance use among young adolescents: the case of SwitzerlandArnaud Chiolero, Holger Schmid
Expert Opinion on Investigational Drugs|April 29, 2016
Investigational therapies for renal disease-induced anemiaHolger Schmid, Wolfgang Jelkmann
Pathology|October 1, 2005
Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literatureHolger Schmid, Christian Zietz
International Urology and Nephrology|July 4, 2012
Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes onHolger Schmid, Helmut Schiffl
Expert Opinion on Pharmacotherapy|August 22, 2015
Novel iron-containing phosphate binders for treatment of hyperphosphatemiaHolger Schmid, Stephan R Lederer
American Journal of Medical Genetics. Part A|November 11, 2003
Evidence for systemic manifestations in cerebroretinal vasculopathyJens T Siveke, Holger Schmid
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Expert Review of Hematology|November 18, 2015
Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failureHolger Schmid
Expert Opinion on Pharmacotherapy|March 20, 2013
Peginesatide for the treatment of renal disease-induced anemiaHolger Schmid
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2014
Cost-effectiveness of continuous erythropoietin receptor activator in anemiaHolger Schmid
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 7, 2010
Erythropoiesis stimulating agents and anaemia of end-stage renal diseaseHolger Schmid, Helmut Schiffl
Sozial- Und Praventivmedizin|January 7, 2003
Repeated self-reported injuries and substance use among young adolescents: the case of SwitzerlandArnaud Chiolero, Holger Schmid
Expert Opinion on Investigational Drugs|April 29, 2016
Investigational therapies for renal disease-induced anemiaHolger Schmid, Wolfgang Jelkmann
Pathology|October 1, 2005
Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literatureHolger Schmid, Christian Zietz
International Urology and Nephrology|July 4, 2012
Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes onHolger Schmid, Helmut Schiffl
Expert Opinion on Pharmacotherapy|August 22, 2015
Novel iron-containing phosphate binders for treatment of hyperphosphatemiaHolger Schmid, Stephan R Lederer
American Journal of Medical Genetics. Part A|November 11, 2003
Evidence for systemic manifestations in cerebroretinal vasculopathyJens T Siveke, Holger Schmid
Pageof 9